Data scattered across journals and filing cabinets, finally assembled into one picture
For generations, the global effort to understand and contain sexually transmitted infections has been hampered not by a lack of knowledge, but by a lack of coherence — data existed, but it was scattered, unstandardized, and inaccessible to those who needed it most. In early July 2026, the World Health Organization addressed this structural gap by launching the first open-access global database consolidating quality-assured STI prevalence data from low- and middle-income countries, drawing on 766 studies and more than 2,400 data points gathered since 2010. The act of assembling what was already known — and making it freely available — is itself a form of public health intervention, one that transforms fragmented evidence into the foundation for targeted action.
- Decades of STI research sat siloed across journals, unpublished reports, and institutional archives, leaving policymakers designing interventions on guesswork rather than evidence.
- The absence of standardized, comparable data meant that even well-resourced health ministries could not reliably answer basic questions about which infections were affecting which populations and where.
- WHO's new platform consolidates 2,453 prevalence data points across five major STIs — chlamydia, gonorrhea, herpes simplex virus type 2, syphilis, and trichomoniasis — drawn from household surveys, clinics, adolescent studies, and key population research.
- Strict methodological standards — including minimum sample sizes, clearly defined populations, and data from 2010 onward — ensure the database functions as a quality-controlled resource rather than a simple data dump.
- Designed as a living system, the database will expand to cover additional infections and update continuously as new peer-reviewed studies emerge, keeping pace with shifting epidemiological realities.
- The platform is already positioned to serve a wide coalition of users — from national health ministries and researchers to funders and community organizations — removing the friction between raw data and real-world intervention.
For decades, public health officials confronting sexually transmitted infections faced a paradox: the data they needed existed, but it was scattered across journals, unpublished studies, and institutional archives with no coherent way to access or compare it. In early July 2026, the World Health Organization moved to resolve that paradox, launching the first open-access global database consolidating standardized STI prevalence data from low- and middle-income countries.
The platform brings together information from 766 studies conducted since 2010, yielding 2,453 prevalence data points across five infections: chlamydia, gonorrhea, herpes simplex virus type 2, syphilis, and trichomoniasis. The data spans a wide range of sources — household surveys, studies of pregnant women and adolescents, research among sex workers and other key populations, clinic-based investigations, and baseline data from intervention trials. Every included study had to meet rigorous methodological standards, including clearly defined population groups, sufficient technical detail, and sample sizes of at least 100.
Dr. Tereza Kasaeva, who leads WHO's Department for HIV, TB, Hepatitis and STIs, described the launch as foundational work — the removal of a major barrier between evidence and action. Countries and their partners could now design interventions based on actual epidemiological patterns rather than outdated estimates or informed guesswork.
The database was built to evolve. It will be updated as new peer-reviewed studies emerge and is designed to expand beyond its current five infections as evidence accumulates and priorities shift — a necessary flexibility given that STI patterns, transmission dynamics, and emerging pathogens do not remain static.
The intended audience is deliberately broad. Health ministries, researchers, funders, pharmaceutical companies, and community organizations all have distinct but overlapping reasons to understand where infections are concentrated and among whom. What WHO has created is, at its core, infrastructure — the unglamorous but essential kind that allows everything built upon it to function more effectively.
For decades, public health officials trying to understand the true scope of sexually transmitted infections have faced a familiar frustration: the data they needed existed somewhere, scattered across journals and filing cabinets and unpublished research projects, but no one had assembled it into a coherent picture. The World Health Organization moved to change that in early July, launching an open-access database that consolidates standardized prevalence information on five major STIs from low- and middle-income countries, drawing on research conducted since 2010.
The database represents the first attempt to create a single, quality-controlled platform where policymakers, researchers, and public health programs can access comparable data on chlamydia, gonorrhea, herpes simplex virus type 2, syphilis, and trichomoniasis. As of June 2026, it contained information from 766 studies, yielding 2,453 separate prevalence data points. The sheer scale of consolidation matters: these numbers came from diverse sources—household surveys, studies of pregnant women and adolescents, research among sex workers and other key populations, clinic-based investigations, and baseline data from intervention trials. Each study had to meet strict methodological standards: clearly defined population groups, sufficient technical detail, sample sizes of at least 100, and data collection primarily from 2010 onward.
Dr. Tereza Kasaeva, who directs WHO's Department for HIV, TB, Hepatitis and STIs, framed the launch as foundational work. By making these data openly available, she argued, countries and their partners could finally design interventions based on actual epidemiological patterns rather than guesswork or outdated estimates. The database would also strengthen surveillance systems and help accelerate efforts to reduce STI burden globally. What she was describing, in effect, was the removal of a major barrier to action: the absence of reliable, accessible information about who was affected and where.
The database was designed from the start as a living resource. It will be updated as new studies are published and peer-reviewed, and it is built to expand beyond the current five infections as evidence accumulates and public health priorities shift. This flexibility matters because STI epidemiology is not static. Patterns of infection, resistance, and transmission change. New pathogens emerge. Populations move. The tool needed to evolve with the reality it was meant to illuminate.
The intended audience is broad: national health ministries, research institutions, pharmaceutical companies, community organizations, and funding bodies all have reasons to understand STI prevalence patterns. A ministry designing a sexual health campaign needs to know which infections are most common in which regions and among which groups. A researcher planning a trial needs baseline data. A funding agency deciding where to direct resources needs evidence of burden. By consolidating and standardizing information that was previously fragmented, the database removes friction from the process of turning data into action. It is, in other words, infrastructure—the kind of unglamorous but essential work that enables everything else to function more effectively.
Citas Notables
By making these data openly accessible, we are equipping countries and partners with the evidence needed to design targeted interventions and strengthen surveillance systems.— Dr. Tereza Kasaeva, Director of WHO's Department for HIV, TB, Hepatitis and STIs
La Conversación del Hearth Otra perspectiva de la historia
Why does it matter that this data was scattered before? Couldn't researchers just find what they needed?
In theory, yes. In practice, you'd spend months tracking down studies, many of them in languages you don't speak, published in journals you don't have access to, using different methods so you couldn't compare them. Some of the best data never got published at all. Countries were making policy decisions without a clear picture of their own burden.
So this is really about standardization—making apples comparable to apples.
Exactly. If one study defines a population one way and another study defines it differently, you can't say which infection is actually more common. The database enforces consistent definitions and methodological rigor. That's what makes the data usable.
You said it covers five STIs. Why those five?
They're the ones with the most evidence available and the clearest public health impact. But the database is designed to expand. As more research accumulates on other infections, they'll be added.
Who benefits most from this?
Countries with weak surveillance systems benefit enormously. They can now see how their infection patterns compare to similar settings elsewhere, and use that to guide their own responses. Researchers can identify gaps in knowledge. Funders can see where the burden is greatest.
Is there a risk that having standardized data makes people think the problem is solved?
That's a real concern. Data is only useful if it leads to action. The database is a tool, not a solution. It removes one excuse for inaction—not having information—but countries still have to decide what to do with it.